INVENT Pharmaceuticals
"transforming molecules to medicines"

INVENT Pharmaceuticals is developing novel and innovative small molecule drugs for the treatment of serious diseases with high unmet medical need to help improve quality of life of people living with serious diseases.

INVENT Pharmaceuticals is  advancing the development of its  differentiated therapeutics for the treatment of  Cardiopulmonary, Cardiorenal diseases,  Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM), and hATTR Polyneuropathy (hATTR-PN) , Alzheimer's disease, Cognitive Impairment Associated with Schizophrenia (CIAS) and Neuropsychiatric/brain disorders, Neuroendocrine Tumors and other diseases.

We are dedicated to help improve lives of patients by discovering and developing novel, innovative and next generation of safer and effective medicines.